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Hepatitis A virus infection and growth in cultured cells is protracted, cell-type restricted, and generally
not accompanied by the appearance of a cytopathic effect, with the exception of some culture-adapted
strains. We demonstrate that the non-cytopathic HAV strain HM175/clone 1 can be induced to exhibit a
cytopathic phenotype in both persistently or acutely infected cells under co-dependent conditions of
lower incubation temperature (o34 1C) and reduced cell density in both monkey (FRhK-4) and human
(A549) cells. This phenotype is not virus-strain restricted, as it was also observed in cells infected with
HAV strains, HAS-15 and LSH/S. Cytopathic effect was accompanied by rRNA cleavage, indicating
activation of the RNase L pathway, viral negative strand synthesis, caspase-3 activation, and apoptosis.
The results indicate that a cytopathic phenotype may be present in some HAV strains that can be
induced under appropriate conditions, suggesting the potential for development of a plaque assay for
this virus.
Published by Elsevier Inc.Introduction
Hepatitis A virus (HAV) is a member of the picornavirus family
of RNA viruses and currently the only member of the genus
Hepatovirus (Norder et al., 2011). This virus remains the major
causative agent of infectious hepatitis worldwide and is trans-
mitted primarily via the fecal-oral route; its dissemination via
person-to-person contact as well as contaminated food and water
has been documented and is the subject of numerous reviews
(Cliver, 2010; Fiore, 2004; Koopmans and Duizer, 2004). HAV is
stable, relatively resistant to inactivation and decontamination
methods often successful against non-enteric viruses, and can
remain infectious under varying environmental conditions as well
as on environmental surfaces for substantial periods of time.
Early research investigations achieved the ability to culture
HAV derived either directly from human samples or subsequent
to passage of human isolates in monkeys. For example, Provost
and Hilleman (1979) demonstrated that primary cell cultures of
monkey origin were permissive for HAV replication and sup-
ported the production of infectious virus (human isolate) post-
passage in monkeys. Fro¨sner et al. (1979) reported the use of an
established cell culture line that was permissive to replication of
HAV directly following virus extraction from an outbreak (humanInc.
.Q. Wales),
gov (K. Hida),fecal) sample. Other investigators (Flehmig, 1980, 1981; Flehmig
et al., 1981) studied the direct application of human stool samples
containing HAV to a rapidly growing, established cell line without
the requirement for additional agents such as the presence of HBV
genome in the cell line used by Fro¨sner et al. (1979). Subsequent
work from these as well as other investigators revealed signiﬁcant
results regarding the culture adaptation of wild-type strains
(Hollinger, 2001; Nainan et al., 2006; Ross et al., 1991). For
example, HAV infection and growth in cultured cells is cell-type
restricted; permissive replication is typically demonstrated in
primate cells of non-human origin. However, the human cell line
A549 and the embryonic diploid cells WI-38 and MRC-5 have also
been shown to be permissive for at least some strains of HAV.
Following acute infection in culture, HAV replication is slow,
requiring weeks/months for consistent detection of expressed
viral antigen and/or particles without onset of a cytopathic effect
and thus can establish a persistent (steady-state) infection. Serial
passage/sub-culture of HAV strains can result in culture-adapta-
tion of the virus typically deﬁned by increased virus replication
rates and expression of viral antigen, and has been achieved with
various strains from human isolates as well as monkey passaged
human virus (Binn et al., 1984; Bradley et al., 1984; Daemer et al.,
1981; Flehmig, 1980; Flehmig et al., 1981; Fro¨sner et al., 1979;
Gauss-Mu¨ller et al., 1981; Kojima et al., 1981; Provost and
Hilleman, 1979). Indeed, these persistently infected cell lines
can be routinely sub-cultured, as with the uninfected parental
line, often for up to a year without overt induction of apoptosis,
cpe or dramatic changes in morphologic appearance, but with
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The reason(s) for the protracted replication rate of wild-type virus
and culture-adapted strains (despite the improved replication of
the latter compared to the former) is not completely known;
however, it has been posited that HAV, which lacks a host shut-off
function typical of other picornaviruses, competes for critical
cellular factors essential for virus gene expression and replication
(Bedard and Semler, 2004; Pinto et al., 2007). Alternatively, it has
been suggested that slow replication and virus particle matura-
tion/yield may be the consequence of ongoing encapsidation of
the viral RNA pool, asynchronous replication, down regulation of
viral RNA replication or rate-limiting viral translation (Anderson
et al., 1988; Cho and Ehrenfeld, 1991; De Chastonay and Siegl,
1987; Funkhouser et al., 1999).
The serial passage of cell-culture adapted non-cytopathic HAV
strains has resulted in the emergence of even faster growing
strains capable of inducing a cytopathic effect (cpe) during virus
replication. Interestingly, the induction of cpe appears to be
restricted to particular cell lines, for example FRhK-4 (and their
derivative Frp/3), B-SC-1 and A549 cells (Ali, 2002; Anderson,
1987; Cromeans et al., 1989; Cromeans et al., 1987; Divizia et al.,
1986; Gaspar et al., 1992; Lemon et al., 1991; Nasser and Metcalf,
1987; Venuti et al., 1985); the reason(s) for this cell restricted
phenotype is not yet fully understood. In this regard, both non-
cpe and cpe HAV strains remain of interest to investigators
particularly those studying the processes responsible for viral
replication and cpe induction by HAV and the contribution of
mutations in the viral genome to these processes (Beneduce et al.,
1995; Brack et al., 1998; Cohen et al., 1989; Emerson et al., 1991;
Funkhouser et al., 1994; Jansen et al., 1988; Lemon et al., 1991).
Induction of cpe is also of interest to investigators in providing a
mechanism by which to quantitate viral replication. Given the
non-cytopathic nature of wild-type and culture-adapted HAV
strains, early investigators applied techniques such as radioim-
munoassay (RIA), direct and indirect immunoﬂuorescence, and
immune electron microscopy to evaluate whether virus replica-
tion and gene expression occurred in HAV infected cells.
The quantiﬁcation/titration of HAV infectivity later included
established methods such as radioimmunofocus assays (RIFA),
immunoﬂuorescence, ELISA, RT-PCR, immunological-based focus
assays, and in situ hybridization (Jansen et al., 1985; Lemon et al.,
1983; Richards and Watson, 2001; Siegl et al., 1984a; Yeh et al.,
2008). Notably, a plaque assay has not been developed for either
wild-type or culture-adapted HAV due to the absence of cyto-
pathogenicity of these strains. However, there is a real need for a
relatively simple quantitative methodology that does not involve
radionuclide(s) and demonstrates both infectivity and production
of infectious progeny, all features that a plaque assay would
provide.
During the present investigation, we discovered that culture
incubation temperature can affect the phenotype of a culture-
adapted, non-cytopathic HAV strain (HM175/clone 1) during
persistent infection. We then sought to determine what other
incubation and infection parameters can affect the regulation and
expression of this phenotype. Our results indicate that (i) culture
incubation temperature in combination with cell culture density
affect the temporal onset of cpe, (ii) cpe is the result of the
induction of caspase-dependent apoptosis in persistently infected
cells and is commensurate with caspase activation in acutely
infected cells, (iii) development of cpe is not the result of an
abortive infection as viral protein (capsid) and negative strand
synthesis is readily detected during infection, and (iv) the induc-
tion of cpe occurs during acute infection with three culture-
adapted, non-cytopathic HAV strains and, therefore, is not solely a
viral strain restricted phenomenon. Interestingly, the induction
of cpe/apoptosis in infected cells is preceded by rRNA cleavage(viz. activation of the OAS/RNase L pathway) and therefore may
be dependent on the activation of the OAS protein. We postulate
that other non-cytopathic HAV strains may also be similarly
affected to induce apoptosis/cpe in a manner that is likely co-
dependent on these and other factors such as virus replication
rate, the presence/absence of critical cell regulatory factors and
possibly the activation of the RNase L pathway.Results
Induction of cpe phenotype in HM175/clone 1 infected cells during
incubation at 33 1C
In our laboratory, the regular growth and maintenance of FRhK-
4 (monkey) cells, as well as FRhK-4 cells persistently infected with
HAV HM175/clone 1 (also called clone 1 cells (Kulka et al., 2009))
are typically conducted at an incubation temperature of 37 1C
(Goswami et al., 2004; Kulka et al., 2009; Kulka et al., 2003). Clone
1 cells can be sub-cultured on a weekly basis up to 240 days post
infection (dpi) without the appearance of cpe and preliminary
studies in our laboratory have shown that continuous sub-culture
for up to approximately 1 year pi is possible, albeit with subtle
morphologic changes becoming increasingly visually evident as the
period of sub-culture increases (beginning at approximately 250
days pi) (data not shown). During routine sub-culturing we
discovered that incubation of persistently infected cells at 34 1C
resulted in the onset of a ‘‘cpe-like’’ morphology after 7 days (data
not shown). Continued investigation revealed that the induction of
cpe was visually discernible beginning at approximately 3–4 days
growth at either 33 1C or 34 1C (data not shown). As discussed in
the Materials and Methods, we conducted further investigations at
33 1C unless otherwise stated. In Fig. 1, the effect of 33 1C incuba-
tion is shown for FRhK-4 cells either uninfected or persistently
infected with HM175/clone 1 using brightﬁeld microscopy (panels
(A)–(C)). Persistently infected cells cultured at 37 1C (panel (B))
have a morphologic appearance similar to that observed for
uninfected FRhK-4 cells cultured either at 37 1C (data not shown,
Goswami et al., 2004) or 33 1C (panel (A)). When persistently
infected cells are cultured at 33 1C, the development of cpe-like
morphology is observed beginning at day 4 (data not shown). Both
the number and the severity of cells exhibiting this morphology
increases with increasing time of incubation at 33 1C and is shown
for persistently infected cells at day 6 (panel (C)), and it is easily
distinguishable from similarly sub-cultured cells incubated at 37 1C
(panel (B)).
We were interested in determining whether the apparent
temperature-dependent morphologic change observed in the
infected FRhK-4 cells is restricted to a given cell-type. To this
end we established an HM175/clone 1 persistently infected A549
(human) cell line as these cells have been reported previously to
support the replication of HAV (Cromeans et al., 1989). As shown
in Fig. 1, persistently infected A549 cells cultured at 37 1C (panel
(E)) demonstrate little morphologic differences from uninfected
A549 cells at either 37 1C (data not shown) or 33 1C (panel (D)).
As with FRhK-4 cells, cpe-like morphology develops at approxi-
mately 4 days (data not shown) and increases with time of
incubation at 33 1C and is readily apparent at day 6 (panel (F)),
and it appears that both persistently infected cell lines grow more
slowly at 33 1C than at 37 1C (data not shown). Importantly, the
results indicate that induction of cpe is co-dependent on HAV
infection and incubation temperature, and is not cell type
restricted. Indeed, we believe that the induction of cpe during
cell culture infection with a non-cytopathic strain of HAV is a
signiﬁcant discovery since as far as we are aware it has not been
previously reported in the literature.
Fig. 2. Analysis of rRNA cleavage in FRhK-4 and A549 cells persistently infected
with HM175/clone 1 and cultured at either 33 1C or 37 1C. Uninfected and clone
1 persistently infected FRhK-4 cells (A) and uninfected and clone 1 persistently
infected A549 cells (B) were seeded at 4000 and 6000 cells/cm2, respectively,
cultured for 6 days at either 33 1C or 37 1C prior to harvest for cytoplasmic RNA,
and analyzed (3.5 mg) for RNA cleavage by agarose gel electrophoresis (Goswami
et al., 2004). The 28S and 18S rRNAs are identiﬁed with arrows. Cleavage of rRNA
is not observed in uninfected cells or persistently infected cells at 37 1C.
Fig. 1. Brightﬁeld microscopy for the examination of HM175/clone 1 persistently infected or uninfected FRhK-4 or A549 cells following growth at either 33 1C or 37 1C.
Uninfected and persistently infected FRhK-4 ((A)–(C)) and A549 ((D)–(F)) cells were seeded at 4000 and 6000 cells/cm2, respectively, then cultured for 6 days at either
33 1C ((A), (C), (D), (F)) or 37 1C ((B), (E)). Cultures were observed over the 6 days incubation period by brightﬁeld microscopy and images were obtained and shown for day
6 of the culture period.
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We have previously shown that FRhK-4 cells are permissive for
HAV replication and that rRNA cleavage in these cells can be
detected as early as 16 h pi with HAV HM175/18f without prior
treatment with IFN but cannot be detected in HAV HM175/clone
1 infected (acute or persistent) cells (Kulka et al., 2009; Kulka
et al., 2003). We also established that the RNA cleavage in 18f
infected cells was indicative of an activated RNase L since its
characteristic pattern (and attribution to RNase L activation) was
as described by others (Cayley et al., 1982; Kulka et al., 2009;
Silverman et al., 1983; Wreschner et al., 1981) and its detection
was commensurate with the presence of the well-characterized
activator of RNase L, 2–5 A (Kulka et al., 2009).
Given the striking similarity between the cpe observed in Fig. 1
panels (C) and (F) and our previous observations of 18f infected
FRhK-4 cells (Goswami et al., 2004; Kulka et al., 2009; Kulka et al.,
2003), we hypothesized that the induction of cpe in clone
1 persistently infected FRhK-4, as well as A549, cells may involve
rRNA cleavage, i.e., activation of the OAS/RNase L pathway.
Therefore, we monitored rRNA cleavage in both FRhK-4 and
A549 cells either uninfected or persistently infected with clone
1 at 37 1C as well as 33 1C (Fig. 2). While rRNA cleavage is not
observed in uninfected FRhK-4 or A549 cells (Fig. 2, panels (A)
and (B), respectively) at either temperature, both persistently
infected cell lines exhibit a strong induction of rRNA cleavage at
4 and 6 days post-culture at 33 1C, but not at 37 1C (shown only
for day 6 post-culture). Activation of RNase L in these cells
appears restricted by both incubation temperature and prior virus
infection. Interestingly, the activation of RNase L in both persis-
tently infected cell lines occurs in conjunction with the develop-
ment of cpe at 33 1C, as previously reported by Kulka et al. (2009)
for the cytopathic strain HM175/18f in FRhK-4 cells at 37 1C.
Unlike infection with 18f, however, the activation of RNase L in
persistently infected cell lines does not occur at 37 1C.
Caspase activation in FRhK-4 or A549 cells persistently infected with
HM175/clone 1
It has been previously shown that cpe/apoptosis in HM175/18f
infected FRhK-4 cells is caspase-dependent (Goswami et al.,2004), therefore, we ﬁrst sought to determine whether we could
detect caspase activation in situ in both HM175/clone 1 persis-
tently infected cell lines. Thus, both persistently infected cell lines
were grown for 5 days at 33 1C or 37 1C prior to treatment with
10mM FITC-labeled z-VAD-fmk. This modiﬁed pan-caspase inhi-
bitor binds to the active form of caspases at a concentration and
treatment period insufﬁcient to inhibit caspase activity (Goswami
et al., 2004, data not shown). The results of ﬂuorescent micro-
scopy for these treated cells are shown in Fig. 3. Uninfected cells
grown at 33 1C or persistently infected cells grown at 37 1C are
negative for ﬂuorescence while both infected cell lines are
positive for ﬂuorescence at 33 1C indicating that caspase(s) are
activated in these cells. Fluorescent staining is characterized by a
few cells with intense ﬂuorescence and approximately 50% of the
remaining cells exhibiting punctate, albeit weaker, ﬂuorescence.
We interpret the weak but uniform staining as consistent with
the initiation of apoptosis and progressive development of cpe
observed over time (4 to 6 days) in these cells at 33 1C. Indeed, the
data suggests that RNase L activation (viz. rRNA cleavage) may
precede the onset of apoptosis as previously observed for 18f
infected cells (Goswami et al., 2004; Kulka et al., 2009).
Fig. 3. Fluorescent microscopy for the examination of HM175/clone 1 persistently infected FRhK-4 and A549 cells treated with FITC-labeled z-VAD-fmk. Uninfected and
clone 1 persistently infected FRhK-4 ((A)–(F)) and A549 ((G)–(L)) cells were seeded (in 5 cm2 wells) at 4000 and 6000 cells/cm2, respectively, then cultured for 5 days at
either 33 1C ((A), (B), (E)–(H), (K), (L)) or 37 1C ((C), (D), (I), (J)). All cells were incubated in the presence of 10 mM FITC-labeled z-VAD-fmk for 4 h on day 5 in culture prior to
cell ﬁxation then subjected to brightﬁeld ((A), (C), (E), (G), (I), (K)) and ﬂuorescent ((B), (D), (F), (H), (J), (L)) microscopic examination as described in Materials and methods.
Fig. 4. The effect of temperature on the expression and processing of HAV viral
capsid protein VP-1 and caspase-3 in clone 1 persistently infected FRhK-4 and
A549 cells. Protein extracts (25 mg) were analyzed for VP-1 expression and
processing in both uninfected and persistently infected cell lines (A). Cells were
seeded at 4000 and 6000 cells/cm2 respectively, and cultured for 6 days at either
33 1C or 37 1C prior to harvest for analysis by western blot using afﬁnity puriﬁed
anti-VP-1 antibody. The blots were stripped, washed and re-probed with anti-
caspase-3 for analysis of caspase-3 expression and cleavage (B). The blots were
re-stripped, washed and re-probed with anti-actin antibody (C). The positions of
the HAV precursor proteins P1-2A and VP1-2A as well as the fully processed VP-1
are identiﬁed with arrows in panel (A). In panel (B), the positions of full-length
caspase-3 (non-activated) and the p20 peptide of activated caspase-3 are identi-
ﬁed with arrows. In some lanes, the mature p17 subunit is also visible.
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1 persistently infected cells are caspase-dependent
We next sought to determine whether apoptosis was actually
occurring in persistently infected cells during incubation at 33 1C.
To this end, activation of caspase-3 (viz. caspase-3 cleavage) and
formation of DNA laddering were examined in these cells, as well
as in uninfected cells as negative controls. Western blot analysis
of VP-1 expression was used to monitor viral capsid expression as
an indicator of virus replication concomitant with any develop-
ment of apoptosis. The anti-VP1 antibody has been shown to
detect HAV VP-1 protein when it is part of a larger precursor
protein as well as in its fully processed form (Goswami et al.,
2004; Kulka et al., 2009, 2003).
The results of the analyses of VP-1 expression, caspase-3
expression/cleavage and actin levels for uninfected and persis-
tently infected FRhK-4 and A549 cells at 33 1C and 37 1C are
shown in Fig. 4. Strong VP-1 expression (panel (A)) is detected in
persistently infected cells at 33 1C and 37 1C indicating successful
virus infection and replication in these cells. A non-speciﬁc
cellular cross-reactive band is also present in uninfected FRhK-4
and A549 cells, though it migrates slightly higher than VP-1 upon
close inspection. Despite the intensity of cpe observed in Fig. 1,
expression of both partially processed (P1-2A and VP1-2A) and
fully processed capsid protein VP-1 appear more robust at 33 1C,
particularly in A549 cells, suggesting viral protein expression/
processing is largely unaffected by those processes (viz. cell
death) responsible for the cytopathic phenotype. Indeed, the
increase in viral protein levels is commensurate with develop-
ment of cpe in these cells. Most interesting, however, are the
results indicating that the major effector caspase, caspase-3, is
only cleaved/activated in infected cells at 33 1C and increases
with the time of incubation (Fig. 4, panel (B)). This indicates that
caspase pathway activation occurs in conjunction with develop-
ment of cpe in both persistently infected cell lines. The levels
of VP-1 and caspase-3 expression/processing are not due to
differences in gel (lane) loading, as actin levels are essentially
equivalent among all samples (Fig. 4, panel (C)).
To conﬁrm whether apoptosis occurs in these infected cells,
we obtained extracts derived from persistently infected FRhK-4
and A549 cells, as well as uninfected parental cells, incubated at
either 37 1C or 33 1C for analysis of cytoplasmic DNA laddering.The appearance of DNA laddering in the cytoplasm is an indicator
of an activated apoptotic process (Brack et al., 1998; Goswami
et al., 2004). Cleavage of DNA is also observed after 4 days at 33 1C
Fig. 5. The effect of z-VAD-fmk on ribosomal RNA cleavage, DNA laddering, and cytopathic effect in FRhK-4 and A549 cells persistently infected with HM175/clone
1 cultured at 33 1C. Total cytoplasmic nucleic acid extracts were obtained from persistently infected FRhK-4 (Fr-cl 1) and A549 (A5-cl 1) cells and analyzed for DNA
laddering (A) and rRNA degradation (B) by agarose gel electrophoresis as previously described (Goswami et al., 2004). Cells were seeded at 4000 cells/cm2 (Fr-cl 1) or 6000
cells/cm2 (A5-cl 1) and cultured for 6 days at 33 1C in the absence () or presence (þ) of 50 mM z-VAD-fmk (for the last 5 days in culture) prior to harvest for extraction of
cytoplasmic nucleic acid. The 28S and 18S rRNAs are identiﬁed with arrows. Persistently infected FRhK-4 ((C) and (D)) and A549 ((E) and (F)) cells were seeded at 4000 and
6000 cells/cm2 respectively, then cultured for 6 days at 33 1C in absence ((C) and (E)) or presence ((D) and (F)) of 50 mM z-VAD-fmk (for the last 5 days in culture). Cultures
were observed over the 6-day incubation period by brightﬁeld microscopy and images were obtained and shown for day 6 of the culture period.
Table 1
Analysis of cpe, RNase L activity and apoptosis as a function of time and
temperature of incubation and cell density in persistently infected cell lines.
Cell linea Treatmentb Subculture
Densityc
Cped rRNA
Cleavagee
DNA
Ladderingf
FRhK-4/clone1 4d 33 1C 4,000 þ þ þ
6d 33 1C 4,000 þ þ þ
6d 37 1C 4,000   
6d 33 1C/1%
FCS
4,000 þ þ þ
6d 37 1C/1%
FCS
4,000   
6d 31.5 1C 4,000 þ þ þ
6d 33 1C 20,000  þ 
6d 37 1C 20,000   
A549/clone 1 4 d33 1C 6,000 7 þ 7
6d 33 1C 6,000 þ þ 
6d 37 1C 6,000   
6d 33 1C 40,000  þ 
6d 37 1C 40,000   
a HM175/clone 1 persistently infected FRhK-4 (105–140 dpi) or A549 (70–
141 dpi) cells. VP-1 expression was detected in all infected cells under all
conditions of treatmentb (data not shown). Uninfected FRhK-4 and A549 cells
were also treated as infected cells, with all negative results (data not shown).
b Indicated cell lines were incubated at either 33 1C or 37 1C for indicated days
in growth media containing 5% and 10% heat-inactivated FCS for FRhK-4 and A549
cells, respectively, unless otherwise indicated.
c Subculture density is given as number of cells per cm2 culture vessel surface
area.
d,e,f Results expressed as positive (þ), weakly positive (7), or negative () for
cpe, rRNA cleavage and DNA laddering as described in Materials and Methods.
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DNA fragment staining observed in the infected FRhK-4 cell line
(data not shown). As shown in Fig. 5 (panel (A)), apoptotic DNA
laddering is evident in both FRhK-4 and A549 cells persistently
infected with HM175/clone1 grown for 6 days at 33 1C. Neither
persistently infected cells incubated at 37 1C nor uninfected cells
incubated at either temperature show any evidence of DNA
laddering (data not shown). The presence of DNA laddering is
coincident with cleavage of caspase-3 shown in Fig. 4 (panel (B))
for the infected cell lines grown at 33 1C indicating a good
correlation between these two events. Therefore, we examined
the possibility of caspase-dependent apoptosis in both clone
1 infected cell lines by determining the effect of the pan-caspase
inhibitor (z-VAD-fmk) on DNA laddering. As shown in Fig. 5
(panel (A)), incubation of either persistently infected cell line at
33 1C (for 6 days) in the presence of z-VAD-fmk (from days 1 to 6)
completely abrogated DNA laddering. As previously reported for
18f infected FRhK-4 cells (Goswami et al., 2004), similar incuba-
tion and treatment of either persistently infected cell line with
z-VAD-fmk had no effect on rRNA cleavage in either clone
1 infected cell line (Fig. 5, panel (B)) indicating that rRNA cleavage
(and thus RNase L activation) is not a consequence of apoptosis in
these cells. Importantly, we observed a concomitant and signiﬁ-
cant reduction of cpe (4 90%) in infected FRhK-4 cells and A549
cells both treated with 50 mM z-VAD-fmk (Fig. 5, panels (D) and
(F), respectively) compared to untreated, infected cells (Fig. 5,
panels (C) and (E), respectively). Since z-VAD-fmk does not affect
replication of HAV (Goswami et al., 2004; data not shown) at
concentrations used in this study, the data indicate that HAV
HM175/clone 1 permissive infection (persistent) is subject to
temperature dependent induction of apoptosis resulting in the
establishment of cpe in FRhK-4 and A549 cells.
The development of cpe, RNase L activity, and apoptosis are affected
by time and temperature of incubation, and cell density seeding
During the course of our investigation we discovered that the
onset, establishment, and maintenance of cpe, rRNA cleavage and
DNA laddering were affected by a number of experimental
variables, e.g., time of incubation at 33 1C, time of incubation
(sequential) at 37 1C prior to (or following) incubation at 33 1C,
and cell seeding ratio/density. For example, in persistently
infected FRhK-4 cells (sub-cultured at ratios of 1:20–1:40) we
observed that incubation at 37 1C forZ4–5 days prior to incubat-
ing the cultures at 33 1C yielded cultures without evidence of cpe
(data not shown). However, reducing the initial time at 37 1C to1–2 days led to cpe (and DNA laddering) when the cultures were
further incubated at 33 1C for at least 4–6 days (data not shown).
Finally, lower sub-culture ratios (less than 1:20) negatively
affected the onset of cpe and DNA (data not shown). We inter-
preted these results to suggest that cell density, particularly in
relation to time of incubation at 33 1C, may inﬂuence whether
induction of apoptosis (i.e., cpe) will occur.
In order to better control for the potential effect of cell density,
we determined in preliminary experiments that seeding densities
of approximately 4000 cells/cm2 and 6000 cells/cm2 for FRhK-4
and A549 cells, respectively, were adequate to yield cellular
extracts of sufﬁcient quantity for cytosolic nucleic acid analysis
in combination with observation of cpe induction. Subsequent
investigations were designed to examine several experimental
parameters and representative results are shown in Table 1.
For example, in both infected cell lines cultured at 33 1C (but
not 37 1C) the development of cpe is observed at approximately
Fig. 6. Brightﬁeld microscopy for the examination of the effect of cell density on
induction of cpe at 33 1C and 37 1C in HM175/clone 1 infected A549 cells. A549
cells were seeded at 12,000 ((A) and (B)) and 600 ((C) and (D)) cells/cm2, cultured
for 4 days at 37 1C prior to infection with HM175/clone 1 at an moi of 5–8, and
infected cell cultures were incubated at either 37 1C ((A) and (C)) or 33 1C ((B) and
(D)). Cultures were observed over a 10-day incubation period by brightﬁeld
microscopy and images were obtained and shown for day 10 of the culture period.
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time of incubation such that they remain positive at 6 days.
Cleavage of rRNA is consistently observed under these incubation
conditions. The destruction of the monolayer continues beyond 6
days and a concomitant increase in extent of rRNA cleavage and
DNA laddering is likewise observed (data not shown). As shown in
Table 1, neither a reduction in serum concentration to 1% nor a
reduction in the incubation temperature to 31.5 1C had any
signiﬁcant inhibitory effect on the induction of cpe, rRNA cleavage
or DNA laddering in persistently infected cells at 33 1C. In contrast,
increasing the seeding density of persistently infected FRhK-4 cells
to 20,000 cells/cm2 completely abolishes the development of cpe
even after 6 days at 33 1C. Interestingly, rRNA cleavage was not
abolished with increased seeding density. Similar results are
achieved with persistently infected A549 cells seeded at 6,000
cells/cm2 versus 40,000 cells/cm2 suggesting the results are not
unique to a given cell type/species. In addition, we have consis-
tently observed throughout our investigation that cpe, rRNA
cleavage and DNA laddering are not observed in either persistently
infected cell lines incubated at 37 1C (Table 1) or in either parental
uninfected cell lines incubated at 33 1C or 37 1C (data not shown).
In summary, these results indicate that in either persistently
infected cell line a cytopathic effect is accompanied by the
detection of rRNA cleavage (i.e., RNase L activation) and cas-
pase-dependent DNA laddering (i.e., apoptosis) at 33 1C. While
the presence of DNA laddering in the absence of rRNA cleavage or
cpe has not been observed, rRNA cleavage occurs in the absence of
cpe and DNA laddering when cells are seeded at a higher density
sufﬁcient to achieve conﬂuence in less than 3–4 days at 33 1C.
Cell density dependence of cpe induction in A549 cells acutely
infected with HM175/clone 1
We considered that the induction of cpe could be due to the
effect of putative mechanism(s) and/or factor(s) responsible for
maintenance of a persistent state of infection. As a consequence,
cpe may not occur during an acute HAV infection with HM175/
clone 1. To explore this possibility, we acutely infected conﬂuent
A549 cells with HM175/clone 1 from the ATCC stock vial used to
establish our persistent lines at 37 1C. As shown in Fig. 6 (panels
(A) and (B)) at 10 dpi, cpe does not occur at either 33 1C or 37 1C
when cells were infected at conﬂuency. However, given that
subculture seeding density appears to affect the onset of cpe in
persistently infected cells (Table 1), we sought to determine
whether cpe occurs when sub-conﬂuent A549 cells were used
for infection. Indeed, a cytopathic effect is readily observed at
33 1C, but not 37 1C, at 10 dpi following sub-conﬂuent infection
with HM175/clone 1 (Fig. 6, panels (D) and (C), respectively;
Table 2) with onset initially observed at 6 days pi (data not
shown). A cytopathic effect was also observed following acute
infection with HM175/clone 1 in FRhK-4 cells (Table 2) whereby
cpe (albeit weaker) is observed only at 33 1C and when cells were
infected at subconﬂuency. These results indicate that induction
of apoptosis/cpe at 33 1C does not require establishment of a
persistent infection.
Acute infection with either HAV strain HAS-15 or LSH/S and induction
of cpe in FRhK-4 and A549 cells as a function of incubation
temperature and cell density
To further examine whether the temperature/cell density-
dependent cpe phenotype may be unique to the HM175/clone
1 strain of HAV, we obtained two additional non-cytopathic HAV
(culture-adapted) strains, LSH/S and HAS-15, from a commercial
source for investigation of cpe at 33 1C following acute infection
of either FrHK-4 or A549 cells. As indicated in Table 2, all threestrains exhibit cpe following acute infection of sub-conﬂuent cells
and incubation at 33 1C, but not at 37 1C. In contrast, there was no
evidence of cpe following infection of conﬂuent cells with any of
the strains regardless of the temperature of incubation. Interest-
ingly, as with HM175/clone 1, there was variability in cpe
depending on the virus strain/cell line combination. For example,
while onset of cpe occurs at 33 1C in FRhK-4 and A549 cells
infected with HAS-15, the cpe is relatively more intense in FRhK-4
cells. The results with LSH/S are essentially the reverse of those
obtained with HAS-15 whereby strong cpe was observed in A549
cells with little or no cpe detected in similarly infected FRhK-4
cells. These differences are not readily explained by an absence of
infection since strong expression of VP-1 was detected in all sub-
conﬂuent infected cells cultured at 33 1C (data not shown). In
summary, the results indicate that the induction of cpe following
acute infection with three different HAV strains does occur, but
does so as a function of temperature, cell density at the time of
infection, and virus strain/cell line combination for infection.
Analysis of RNase L activation and apoptosis following sub-culture of
cells acutely infected with HM175/clone 1, LSH/S or HAS-15
Interestingly, previous investigations into the establishment of
persistently infected lines have included reduced temperature
culture conditions (i.e., o37 1C), yet there has been no report of
an induction of cpe under these conditions. We believe the
absence of cpe in those studies was at least in part due to the
use of conﬂuent cells to establish a persistent infection (Anderson,
1987; Dotzauer et al., 1994; Goswami et al., 2004; Kulka et al.,
2009; Simmonds et al., 1985; Vallbracht et al., 1984) as we have
conﬁrmed the absence of cpe at 33 1C following the acute
infection of FRhK-4 or A549 cells at conﬂuency with three
different virus strains, HM175/clone 1, HAS-15 or LSH/S (Fig. 6
and Table 2). However, we were curious to determine whether
the apparent density-dependent restriction/inhibition of cpe in
infected cells was irreversible. To this end, acutely infected
(conﬂuent) cells were cultured at 37 1C or 33 1C for 3 dpi before
the cultures were sub-cultured (at low density) for continued
incubation (5 days) at the respective temperatures of 37 1C or
Table 2
Analysis of cpe as a function of time and temperature of incubation and cell density in acutely infected cells.
cpea cpea
Cell line/virus Densityb 33 1C 37 1C Cell line/virus Densityb 33 1C 37 1C
FRhK-4/clone1 Conﬂuent   A549/clone1 Conﬂuent  
Sub-conﬂuent þ  Sub-conﬂuent þþ 
FRhK-4/HAS-15 Conﬂuent   A549/HAS-15 Conﬂuent  
Sub-conﬂuent þþ  Sub-conﬂuent þ 
FRhK-4/LSH/S Conﬂuent   A549/LSH/S Conﬂuent  
Sub-conﬂuent 7  Sub-conﬂuent þþþ 
a Infected cell cultures were incubated at either 33 1C or 37 1C for determination of cpe at 10 dpi. Results expressed as a weakly positive (þ), positive (þþ), strongly
positive (þþþ), or negative ().
b To obtain either conﬂuent or sub-conﬂuent cell monolayers at the time of virus infection, FRhK-4 or A549 cells seeded at 400 and 600 cells/cm2, respectively (for sub-
conﬂuency), or 10,000 and 12,000 cells/cm2, respectively (for conﬂuency), and cultured for 4 days at 37 1C prior to infection with the indicated virus at an moi of 5.
Fig. 7. The effect of subculture and temperature on rRNA cleavage, the expression and processing of HAV viral capsid protein VP-1, caspase-3, and the induction of cpe in
FRhK-4 or A549 cells infected with different HAV strains. Conﬂuent FRhK-4 or A549 cells were either mock (I–III), HM175/clone 1(I), LSH/S (II), or HAS-15 (III) infected
(moi. of 5–8) and cultured at either 33 1C or 37 1C for 3 days. At 3 dpi, the cells were subcultured at low density (1:20 and 1:30 for mock or infected, FRhK-4 and A549 cells,
respectively), and incubation continued at the same temperature for an additional 5 days (i.e., 8 dpi total). Cultures were harvested as replicate cell pellets to obtain
cytoplasmic RNA obtained for analysis (3.5 mg) of RNA cleavage by agarose gel electrophoresis (A) (Goswami et al., 2004), and protein extracts for immunoblot analysis
(25 mg) of HAV VP-1 expression and processing (B). The blots were stripped, washed and re-probed with anti-caspase-3 for analysis of caspase-3 expression and cleavage
(C). The blots were re-stripped, washed and re-probed with anti-actin antibody (D). The 28S and 18S rRNAs are identiﬁed with arrows in panel (A). The positions of the
HAV precursor protein VP1-2A as well as the fully processed VP-1 are identiﬁed with arrows in panel (B). In panel (C), the positions of full length caspase-3 (non-activated)
and the p20 peptide (cleavage product) are identiﬁed with arrows. In some lanes, the mature p17 subunit is also visible.
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both cell lines are shown in Fig. 7. The development of cpe
(sections I–III, panel (E)) was not observed in any infected cells
when incubated at 37 1C for either 3 dpi or following subculture
growth to 8 dpi with the exception of scattered cpe-like ‘‘foci’’ in
HAS-15 infected FRhK-4 cells at 8 dpi (scored as7 in Fig. 7, III,
panel (E)). In contrast, however, a strong cytopathic effect was
observed in both cell lines at 33 1C at 8 dpi, but not 3 dpi,
regardless of the virus strain. The broadest cpe was observed in
FRhK-4 cells infected whereby a cytopathic effect is induced
following infection with each of the three strains at 33 1C and
8 dpi (Fig. 7 I–III, panel (E)). In A549 infected cells there was
variation in the cpe with the strongest cpe following infection
with either LSH/S or HM175/clone 1, and the weakest following
HAS-15 infection. Caspase-3 activation (i.e., cleavage) was only
detected in infected cells under incubation conditions that facili-
tated induction of strong cpe. The weak cpe observed at 8 dpi at
33 1C in HAS-15 infected A549 cells may be due to non-apoptotic
events. It is not due to an insufﬁcient time pi to permit further
development of cpe and/or apoptosis, as these cultures weregrown with routine weekly subculturing for two more weeks at
33 1C with no sign of cpe development, rRNA cleavage, or caspase-
3 activation (data not shown). Interestingly, cpe/apoptosis does
not occur without rRNA cleavage as we have also shown for
persistently infected cells (Figs. 2, 4, 5 and Table 1). However,
rRNA cleavage can occur in the absence of cpe/apoptosis as is
shown for HM175/clone 1 infected FRhK-4 cells at 8 dpi/37 1C and
3 dpi/33 1C (Fig. 7 I, comparing panels (A), (C), and (E)), and HAS-
15 infected FRhK-4 cells likewise at 8 dpi/37 1C and 3 dpi/33 1C
(Fig. 7 III, comparing panels (A), (C), and (E)). Since the infection/
culture protocol used to generate the results in Fig. 7 may be
considered passage one of a persistently infected cell line, it is
interesting to note similar results are obtained in longer passaged,
persistently infected cells (Figs. 2 and 4 and Table 1).
Immunoblot analysis was also used to detect viral protein VP-
1 expression as an indicator of virus replication and the results
are shown in Fig. 7 groups I–III, panel (B). With the exception of
LSH/S infected FRhK-4 or A549 cells where levels of VP-1 decrease
from 3 dpi to nearly (or completely) undetectable levels at 8 dpi
and 37 1C, both cell lines supported the replication of all three
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shown) and VP1-2A proteins] and fully processed VP-1. The
restricted replication at 37 1C is not unexpected given the
reported predilection for replication of LSH/S at 32 1C (Fineschi
et al., 1991; Pellegrini et al., 1993). Importantly, viral capsid
protein expression, and therefore viral gene replication, appears
to occur in cells undergoing cpe/apoptosis. Interestingly, save for
the results in HAS-15 infected A549 cells, the levels of VP-1
(particularly the fully processed protein) are greater at 33 1C than
at 37 1C, with the greatest difference observed at 8 dpi. Generally,
the levels of actin detected by immunoblot were similar within
experimental group samples with the exception of HM175/clone
1 infected A549 cells at 8 dpi 37 1C and 33 1C (Fig. 7 group I, panel
(D)). These samples reveal a 3-fold increase and nearly 0.7-fold
decrease (by densitometric analysis, data not shown), respectively,
compared to other samples in the series and likely reﬂects gel
loading differences. However, these results do not affect the inter-
pretation of the results regarding VP-1 expression, cpe induction and
caspase-3 activation. In summary, these results suggest: (i) the
induction of cpe/apoptosis is not irreversibly blocked by prior
(acute) infection in conﬂuent cells and does not adversely affect
viral gene expression/replication; (ii) the reduction of incubation
temperature may potentiate viral gene expression; and (iii) there is
a positive correlation between activation of caspase-3 and induction
of cpe in these infected cells suggesting apoptosis is responsible for
the observed cytopathogenicity as we demonstrated for persistently
infected cell lines (Fig. 5).
In order to conﬁrm whether viral gene replication is occurring
in infected cells, a portion of the cytoplasmic RNA obtained for the
analysis of rRNA cleavage was held in reserve and used for
negative strand RT-PCR to determine the presence of viral
negative strand synthesis (Kulka et al., 2009). Ampliﬁed samples
representing infected cells at 8 dpi were analyzed by agarose gel
electrophoresis. Negative strand synthesis, and therefore viral
replication, is detected at 8 dpi in infected cell extracts at either
33 1C or 37 1C, except in LSH/S infected FRhK-4 and A549 cells at
37 1C where the HAV amplicon was not detected and weakly
detected, respectively (data not shown). The latter results suggest
that a reduction in virus replication may be responsible for the
reduction in VP-1 expression observed in these cells (Fig. 7 group
II, panel (B)). Additionally, the presence of negative strand synth-
esis in all infected cells undergoing cpe conﬁrms that induction of
cpe/apoptosis does not block virus replication. The results also
indicate that our primer set is suitable for the detection of all
three strains of HAV and may be used to develop an RT-qPCR
protocol for determining whether virus replication/genome
synthesis rates differ among the infected cells.Discussion
HAV replication is protracted, its growth is cell-type restricted,
and it is capable of establishing a persistent infection in vitro that
is particularly evident following continuous passage (subculture)
of an infected cell line (Hollinger, 2001; Nainan et al., 2006; Ross
et al., 1991). Serial passage of wild-type virus strains, derived
from culture supernatants or cell extracts, can result in the
generation of cell-culture adapted strains that typically replicate
faster and express viral proteins earlier post-infection than the
parental wild-type, but remain non-cytopathic. The serial passage
of cell-culture adapted HAV strains results in the emergence of
even faster growing strains capable of inducing a cytopathic effect
(cpe) during virus replication in cell lines such as FRhK-4 and
B-SC-1 (Anderson, 1987; Brack et al., 1998; Cromeans et al., 1989;
Cromeans et al., 1987; Lemon et al., 1991; Nasser and Metcalf,
1987; Venuti et al., 1985).In contrast to those studies, our current investigation reveals
that culture-adapted non-cytopathic strains may already possess
a cytopathic phenotype that is induced under appropriate incuba-
tion conditions. Working initially with persistently HM175/clone
1 infected FRhK-4 and A549 cell lines, we determined that
reducing the temperature (r 34 1C) of incubation during sub-
culture passage of these lines leads to the development of an
easily visible cytopathic effect that appears co-dependent on the
subculture seeding density. The intensity and severity of cpe
increases with the time of incubation at 33 1C whether or not
there was a period of prior incubation at 37 1C. We have observed
that persistently infected cell cultures seeded at densities
whereby they reached conﬂuency at or before 3–4 days atr34 1C
gave acceptable cell quantities for analyses (immunoblot and
cytosolic nucleic acid), but appeared less likely to develop any
remarkable cpe. Ultimately, we determined that seeding densities
of 4000 and 6000 per cm2 of culture area for FRhK-4 and A549
cells, respectively, were sufﬁcient to permit multiple comparative
analyses while at the same time yielding a cytopathic effect. At no
time in our investigation did we observe the induction of
phenotypic changes in uninfected FRhK-4 or A549 cells similar
to those observed in either persistently or acutely infected cells
atr34 1C.
We considered it a possibility that the apparent temperature/
cell density-dependent cpe phenotype in persistently infected
cells may have been the result of either a viral or cellular adaptive
process that occurred during continuous passage of persistently
infected cells, or a property unique to the HM175/clone 1 strain of
HAV. The former would be surprising given our usage of two
different cell lines (monkey kidney versus human lung) to estab-
lish the persistent infections. However, our study also included
investigation of the effect of temperature and density following
acute infection in FRhK-4 and A549 cells using HM175/clone 1 as
well as two additional (and genotypically different (Robertson
et al., 1992) and M. Mammel, personal communication)) HAV
strains. The results indicate that induction of cpe can be made to
occur in acutely infected cell lines with three different virus
strains and was restricted by similar conditions of incubation
temperature and cell density (Fig. 7 and Table 2). One can
conclude, therefore, that induction of apoptosis/cpe at 33 1C does
not require establishment of a persistent infection and is not a
property unique to the HM175 strain of HAV. Alternatively, we
considered the possibility that mechanism(s) responsible for cpe
in persistently infected cells may be different from those occur-
ring in acutely infected cells, such that in persistently infected
cells a selection and/or enrichment of a cytopathic mutant may be
occurring as a consequence of continuous subculture of persis-
tently infected cell lines. This seems an intriguing possibility
particularly since investigators have used HM175 persistently
infected cells as a part of the overall subculture scheme for
generating cytopathic mutants (Anderson, 1987; Cromeans
et al., 1987; Lemon et al., 1991). In their studies, however,
obtaining the cpe mutant usually required clonal isolation follow-
ing acute serial passage(s) in order to obtain the mutant and fully
demonstrate cpe in infected cells, and the process of clonal
isolation and selection (e.g., via limiting dilution, foci or plaque
formation) uses acute infection or ‘‘serial’’ passage depending on
the number of cloning steps. In contrast, Anderson (1987)
reported cytopathology without the need for clonal isolation of
the virus (derived from persistently infected cells) but he did
employ an acute subculture passage prior to observing the
cytopathic effect. Despite their results, we do not believe we have
enriched and/or selected for a cytopathic mutant of HM175 under
conditions of persistent cell passage since (i) neither clonal
isolation nor subculture passage was necessary to establish cpe,
(ii) the cytopathic effect occurs in persistently infected cells at
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despite culture maintenance at 37 1C — a temperature not
conditional for the cpe phenotype, (iii) a single acute infection
with HM175/clone 1 was used to establish persistently infected
cell lines of two different (human, A549 and monkey, FRhK-4) cell
origins without prior serial passage of the virus (in our labora-
tory), and (iv) the development of cpe also occurs in acutely
infected FRhK-4 and A549 cells (Figs. 6 and 7, or Table 2) without
serial virus passage (in our laboratory) and using the same virus
stock as that used to establish the persistently infected cell lines.
Our results obtained following acute infection with the three
different strains of HAV similarly invoke two alternative explana-
tions for the temperature and cell density co-dependent onset of
cpe. One involves an assumption that a sub-population of
cytopathic conditional mutants arises spontaneously following
acute infection and growth of the non-cytopathic virus, and the
other explanation assumes that a cytopathic conditional mutant
sub-population already exists within the non-cytopathic strain
population (commercial stock) that was generated during serial
passage of the stock. Consistent with the pre-existent mutant sub-
population theory, we have observed cellular destruction initially
occurring in only a portion of the cell monolayer and such a limited
destruction may be interpreted as the induction of cpe following
infection by a mutant subset of viruses. The existence of a putative
conditional mutant within multiple commercial virus strains could
have occurred as a consequence of serial passage of virus (or
persistently infected cells) that typically occurs during continuous
large scale virus production (Ali, 2002; Beneduce et al., 1995; Brack
et al., 1998; Cromeans et al., 1989; Divizia et al., 1986; Lemon et al.,
1991; Nasser and Metcalf, 1987; Venuti et al., 1985). However, we
believe this scenario improbable since virus production would have
to generate the same conditional mutation(s) for three different
HAV strains. Rather, we believe the observed temporal onset and
progression of cpe to be a consequence of the asynchronous
replication of HAV. Indeed, this has been proposed as the reason
why the onset of demonstrable viral antigen, production of infec-
tious virus, etc are not similarly observed in, nor achieves a
maximum level, in all cells at the same time, particularly at moiZ5
whereby all cells have been shown to be infected (Anderson et al.,
1988; Cho and Ehrenfeld, 1991; De Chastonay and Siegl, 1987;
Funkhouser et al., 1999). Regarding the argument for spontaneous
mutation during acute infection, we question the probability of
mutations spontaneously arising in two different genotype strains
of HAV [IA for HAS-15 and IB for HM175 and LSH/S] (Robertson
et al., 1992 and Mr. M. Mammel, personal communication) that
would ultimately give rise to nearly identical mutants expressing
the same conditional, cytopathic phenotype. Also, the generation of
a putative mutant under selective/permissive conditions in the
absence of serial virus passage seems unlikely since it would had to
have occurred during both the 10-day acute infection (Fig. 6 and
Table 2), as well as the acute infection coupled with subsequent
subculture (Fig. 7), which have short incubation periods. Indeed, we
must again consider the alternative possibility that culture-adapted
non-cytopathic strains may already possess a cytopathic phenotype
that is induced under relevant incubation conditions such as
decreased cell density and reduced incubation temperature.
With regard to the relevance of cell density and incubation
temperature to cpe, the results from acute infection with and
without subsequent subculture of the infected cells (Table 2
versus Fig. 7) are interesting. For example, persistent HM175/
clone 1 infection of either cell line seeded at low density and 33 1C
gave similar positive results regarding induction of cpe (Figs. 1,
3 and 5; Table 1). When either persistently infected cell line was
seeded at a high density, there was no induction of cpe in either
cell line despite incubation at 33 1C (Table 1). The absence of cpe
at 33 1C following acute infection with HM175/clone 1 (10 dpi) atconﬂuency (Table 2) was reversed in both cells when these
infected cells were subcultured (at 3 dpi) for an additional 5 dpi
(8 dpi and 33 1C; Fig. 7 I, panel (E)). A similar reversal was also
observed for both subcultured lines acutely infected at conﬂuency
(33 1C) with LSH/S, and subcultured FRhK-4 cells infected at
conﬂuency with HAS-15 (compare Table 2 and Fig. 7 II and III,
panel (E)). These results indicate that, with the exception of HAS-
15 infected A549 cells, the absence of cpe observed in cells
acutely infected at conﬂuency is not necessarily irreversible
provided subsequent incubation is at the permissive temperature.
Persistently infected cell cultures maintained and sub-cultured at
conﬂuency at 37 1C, also demonstrate cpe following their sub-
culture at 33 1C (Figs. 1–5, Table 1) suggesting the absence of cpe
in cells infected at conﬂuency and incubated at 37 1C (Table 2) is
likely reversible. It is interesting that acute infection at low cell
density with some virus-cell combinations directly resulted in a
cytopathic effect at 33 1C (10 dpi) without a need for subculture
(Table 2). It is therefore tempting to speculate that it may not be
the act of subculture, but rather low density seeding at the time of
or during infection at 33 1C that is important for induction of cpe.
Ultimately, neither of the permissive culture parameters (33 1C
and cell density) appears individually capable of or responsible
for induction of cpe. Hence, both parameters may be equally
critical and necessary for development of a cytopathic effect and
therefore may be considered co-dependent factors, thus explain-
ing why several investigators that have used temperatures
o34 1C during acute infection/serial passage of HAV or subcul-
ture of persistently HAV-infected cells have not observed a
cytopathic effect (De Chastonay and Siegl, 1987; Fineschi et al.,
1991; Fro¨sner et al., 1979; Pellegrini et al., 1993; Provost et al.,
1982; Siegl et al., 1984a, 1984b).
We have shown that the cytopathic effect is primarily due to
caspase-dependent apoptosis since treatment with z-VAD-fmk
abrogates both the development of cpe and DNA laddering in both
infected cell lines. Importantly, it appears that cpe/apoptosis does
not block virus replication/gene expression as indicated by the
increase in levels of VP-1 concomitant with increasing cpe,
activation of caspase-3 and clearly observable DNA laddering.
Further investigations may include analysis of negative strand
synthesis (as was done for acutely infected cells) or titration of
infectious virus produced in these cells in order to conﬁrm
ongoing virus replication during drug treatment. We have
observed ‘‘residual’’ cpe in persistently infected, z-VAD-fmk
treated cells (approximately 1% in FRhK-4/clone 1 and 5% in
A549/clone 1 cell lines, respectively) and conclude it is likely a
result of the cumulative and detrimental effects on the overall
health of the host cell(s) due to continuing virus replication and
robust expression of viral proteins in the presence of the drug, or
the effects of activated RNase L. We can conclude from our results
that the induction of cytopathogenicity and apoptosis/cpe occurs
only in the presence of virus gene expression or replication. On
the other hand, the reverse does not appear to be so, suggesting
that virus replication and/or gene expression are required, but not
the sole factor, in affecting whether cpe/apoptosis will occur in
virus infected cells. It is interesting to note, however, that the
levels of VP1 expression and processing are generally higher in
acutely infected cells at 33 1C than 37 1C for all three viruses
(Fig. 7 I–III, panel (B)) in both lines, save HAS-15 infected A549
cells. A similar effect of reduced temperature is also observed for
HM175/clone 1 persistently infected A549 cells. Thus, increased
viral gene expression, and possibly replication, correlated with
caspase-3 activation and apoptosis may be factors in the induc-
tion of cpe at 33 1C.
We made an initial investigation into deﬁning what tempo-
rally related process(es) may be functioning to permit induction
of a cytopathic effect following infection with non-cytopathic
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(a consequence of RNase L activation (Goswami et al., 2004; Kulka
et al., 2009, 2003; Nilsen et al., 1982; Silverman et al., 1983;
Wreschner et al., 1981)) is occurring prior to induction of cpe/
apoptosis in HM175/clone 1, HAS-15 and LSH/S infected cells as
was previously reported for FRhK-4 cells infected with the
cytopathic HAV strain 18f (Kulka et al., 2009). Since the pattern
of rRNA cleavage (Figs. 2, 5, and 7) is indicative of an activated
RNase L pathway, we believe that the 20-50oligoadenylate synthe-
tase (2-5OAS)/RNase L pathway has been activated in these cells
as a result of viral dsRNA structures generated during replication
and/or viral RNA folding (Bisbal and Silverman, 2007; Player and
Torrence, 1998). These dsRNA structures function as activators of
the OAS family of proteins that subsequently synthesize unique
2–5 A intermediates and ultimately activate the latent, endogen-
ous RNase L. While HAV and coxsackievirus have been shown to
be refractory to this canonical antiviral pathway (Kulka et al.,
2009), the activation of RNase L has also been implicated in
several cellular functions including in the induction of apoptosis
(Castelli et al., 1998; Rusch et al., 2000; Zhou et al., 1998),
although the mechanisms by which these two processes are
connected are not well understood.
In established, persistently HM175/clone 1 infected FRhK-4 or
A549 cells there was little or no detection of rRNA cleavage at
37 1C (Fig. 2, Table 1; Kulka et al., 2009), yet strong rRNA cleavage
was observed in these cells when at an incubation temperature of
33 1C (4–6 dpi) whether seeded at high or low density (Fig. 2,
Table 1). The cleavage of rRNA was not examined following
continuous acute infection at 10 dpi (Table 2). However, at 3 dpi
rRNA cleavage was not observed in any of the acutely infected
A549 cells at either 33 1C or 37 1C, while cleavage was observed in
3 days post-infected FRhK-4 cells at 33 1C and weakly following
HAS-15 infection at 37 1C Fig. 7 I–III, panel (A)). The passage
(albeit ﬁrst) of these ‘‘persistently’’ infected cells at 33 1C resulted
in the RNase L activation in all except HAS-15 infected A549 cells
and RNase L activation at 37 1C in HM175/clone 1 or HAS-15
infected FRhK-4 cells (Fig. 7). These results suggest that 33 1C
favors RNase L activation in acutely infected FRhK-4 cells while
subculture and growth at either temperature or 33 1C alone may
remove this restriction depending on the cell line. The absence of
cpe (and possibly RNase L activation) in LSH/S infected FRhK-4
cells at 37 1C (Table 2 and Fig. 7 II, panel (E)) is likely due a lack of
sustained growth and replication growth as measured by loss of
negative strand synthesis and VP-1 expression (data not shown
and Fig. 7 II, panel (B)). The reason for the absence of cpe and
RNase L activation in HAS-15 infected A549 cells, despite virus
growth under conditions permissive for cpe in FRhK-4 cells and
viral gene expression (albeit weaker than in FRhK-4 cells), is
currently unknown. However, this outcome is consistent with the
essentially negative cpe observed for HAS-15 acutely infected
conﬂuent A549 cells at 33 1C and 10 dpi (Table 2). We do not
currently know whether differences exist among the infected cell
lines with respect to viral replication rates. Such differences may
affect the quantities of dsRNA sufﬁcient and available to activate
OAS that could account for the differential activation of RNase L
observed among the infected cells under conditions permissive
(or non-permissive) for induction of cpe. While a putative role for
RNase L activation in the induction of the cpe phenotype is
intriguing, its actual contribution remains uncertain in the
absence of further investigation of virus replication rates or
analysis of RNase L activity following virus infection and growth
in permissive cell lines lacking OAS or RNase L. If the activation of
RNase L is involved in the overall process of cpe induction, then
the data appear to suggest the possibility of a two-step process
requiring the activation of RNase L as a prerequisite to induction
of apoptosis/cpe.While previous investigations describe persistent cell cultur-
ing and acute infection (with and without further serial passage of
the virus) at lower temperatures, to the best of our knowledge
they have not used the virus strain/cell line combinations and/or
sub-culturing strategies following initial acute infection that are
described in our investigation (Anderson, 1987; Cromeans et al.,
1987; De Chastonay and Siegl, 1987; Fineschi et al., 1991; Fro¨sner
et al., 1979; Lemon et al., 1991; Pellegrini et al., 1993; Provost
et al., 1982; Siegl et al., 1984a, 1984b). Since we have proven that
the induction of cpe is not restricted to a single cell type, yet have
observed that cpe does not occur in all cell types with the same
virus strain, we believe there is an important cellular contribution
to the cpe effect. To this end, we brieﬂy considered the involve-
ment of cellular ‘‘cold shock’’ proteins, but preliminary data was
inconclusive. It is tempting to entertain the possibility of the
involvement of cell cycle-regulatory proteins which could help
explain the low density requirement. Taken in toto, expression of
a cpe phenotype by a non-cytopathic HAV is the result of
multi-step process that appears co-dependent on incubation
temperature and cell density as well as the activation of relevant
cellular processes by a viral component requiring virus replica-
tion. These culture parameters may be responsible for affecting
molecular processes such as virus replication and/or translation
rates, or the presence/absence of critical cell regulatory factors (in
part determined by the cell species) that ultimately may regulate
the activation of the RNase L pathway and downstream events
such as cpe/apoptosis. Ultimately, it would be both interesting
and important to determine whether the induction of the cpe
phenotype may be possible following cell culture infection with
wild-type strains under the described culture conditions. Any
attempt to investigate the induction of cpe with wild-type strains
may also require co-investigation of the viral and cellular factors
necessary to enhance virus replication. In this regard, under-
standing the mechanism(s) by which the non-cpe strains exhibit a
cpe phenotype under the restricted conditions of reduced incuba-
tion temperature and cell density may provide the information
necessary to reveal the molecular events that may regulate the
non-cpe phenotype of wild-type strains. It is our belief that these
and future investigations may ultimately lead to the development
of methodologies (e.g., plaque assay) that can quantitatively
measure the production of infectious virus.Materials and methods
Cells and viruses
The HM175/clone 1, HAS-15 and LSH/S strains of HAV were
obtained from ATCC (Manassas, VA). These non-cytopathic cell
culture-adapted strains were originally derived from human
isolates (i.e., wild-type strains) (Bradley et al., 1984; Daemer
et al., 1981; Fineschi et al., 1991). In our laboratory the FRhK-4
(fetal rhesus monkey kidney) cell line was originally obtained
from Dr. G. Kaplan (Center for Biologics Evaluation and Research,
FDA) and cultured in MEM supplemented with pyruvate and non-
essential amino acids (Invitrogen, Gibco Cell Products, Carlsbad,
CA) containing 5% heat-inactivated fetal bovine serum. The A549
(human lung carcinoma) cell line purchased from ATCC was
cultured in F-12K medium (ATCC) except with 10% heat-inacti-
vated fetal bovine serum. Procedures for the establishment and
routine maintenance of HM175/clone 1 persistently infected
A549 cell cultures were as previously described for the establish-
ment of HM175/clone 1 persistently infected FRhK-4 cells (Kulka
et al., 2003; 2009; Goswami et al., 2004). Persistently infected
cells were continuously sub-cultured at a split ratio (typically
1:30 to 1:40) sufﬁcient to yield conﬂuent cultures in 6–7 days and
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used throughout the course of this investigation. These persis-
tently infected cells ranged from 70–180 days post-infection for
use in experimental analysis.Antibodies
Rabbit anti-actin antibody was purchased from Sigma-Aldrich
(St. Louis, MO). Rabbit polyclonal antibody to caspase-3 was
purchased from Cell Signaling (Danvers, MA). Polyclonal rabbit
antisera to HAV capsid protein VP1 has been previously described
by Kulka et al. (2009). Goat anti-rabbit and goat anti-mouse
horseradish peroxidase (HRP)-labeled secondary antibodies were
purchased from Pierce Biotechnology Inc. (Rockford, IL).Virus infection and caspase inhibitor treatment
For acute infections, conﬂuent FRhK-4 or A549 cells were
mock, HM175/clone 1, HAS-15 or LSH/S infected at an moi of
5–8 (90 min adsorption at 37 1C followed by removal of adsorp-
tion) for the indicated times at 33 1C or 37 1C in growth media
containing either 1% (FRhK-4) or 10% (A549) heat-inactivated FBS.
Sub-conﬂuent cultures were obtained by seeding at 400 (FRhK-4)
or 600 (A549) cells per cm2 and culture incubation was at the
indicated temperatures for 4 days prior to infection. Replicate
cultures were similarly seeded and incubated to provide average
cell counts prior to virus (or mock) infection at an moi of 5.
Infected (or mock) cell cultures were either maintained at their
respective temperatures or were harvested by scraping. Washed
(once with cold PBS) cell pellets were obtained for subsequent
nucleic acid or protein extraction (Kulka et al., 2003; Goswami
et al., 2004). Persistently HM175/clone 1 infected FRhK-4 and
A549 cells were seeded at the indicated cell densities or sub-
culture split ratios, and cultured in growth media at either 37 1C
or 33 1C for indicated times, and under the given conditions to
obtain cell pellets for nucleic acid or protein extraction as
described above for acutely infected cells. During the course of
these studies and prior to obtaining cells pellets, cultures were
routinely observed and digital images taken using light micro-
scopy. We have observed that development of cpe was indepen-
dent of the culture vessel size.
For treatment with pan-caspase [z-VAD-fmk (Promega Corp.,
Madison, WI)] inhibitor, persistently infected cell lines were seeded
and cultured for 6 days at 33 1C in normal growth media. Growth
media was replaced on days 1, 3 and 5 post-seeding with media
containing 50 mM z-VAD-fmk (or 0.25% DMSO as a negative
control). Cell pellets were obtained on day 6 post-seeding for
nucleic acid extraction as described above for acutely infected cells.
For apoptotic cell labeling with FITC-labeled z-VAD-fmk,
persistently infected cell lines were cultured for 5 days (37 1C or
33 1C) in growth media. Cells were incubated at the respective
temperatures for the ﬁnal 4 h of the culture period in fresh
culture media containing 2% (HM175/clone 1 infected A549 cells)
or 1% (HM175/clone 1 infected FRhK-4 cells) heat-inactivated FBS,
and 10 mM FITC-labeled z-VAD-fmk (Promega Corp). Cell cultures
were then washed twice with room temperature PBS, ﬁxed with
cold methanol in PBS (80% methanol:20% PBS, vol:vol) at 4 1C for
30 min, and washed twice with room temperature PBS. Nuclei
were counter stained with DAPI using SlowFades Gold (Invitro-
gen, Molecular Probes, Carlsbad, CA) according to manufacturer’s
instructions. Parental cell lines (i.e., uninfected) were similarly
cultured, treated with labeled z-VAD-fmk, and subjected to post-
labeling treatment prior to ﬂuorescent microscopy as for the
persistently infected cell lines.Light and ﬂuorescent microscopy
At given days post-infection of acute or mock infection, or
post-seeding of persistently infected or uninfected cells, cell
cultures were observed and digital image photography completed
using brightﬁeld and/or phase contrast microscopy with a Ziess
Axiovert 25 microscope and LCD camera using Axiovision4 soft-
ware (Carl Zeiss, Inc., Thornwood, NY). A Nikon Eclipse TE2000-S
microscope and digital camera in conjunction with Spot 4.7 soft-
ware package (Diagnostic Instruments, Inc., Sterling Heights, MI)
was used for ﬂuorescent microscopy and digital image photo-
graphy of FITC-z-VAD-fmk treated cell cultures.
RNA isolation, rRNA degradation and DNA laddering analysis, and
protein extracts
Total cytoplasmic RNA was isolated for the analysis of rRNA
degradation and DNA laddering by agarose gel electrophoresis as
described previously (Goswami et al., 2004; Kulka et al., 2003).
Similarly extracted RNA was also used for the analysis of viral
negative-strand synthesis by RT-qPCR. RNA concentrations were
calculated from the absorbance measured at 260 nm. Protein
extracts were obtained as total cell (soluble) lysates from mock
or virus infected cells using RIPA buffer (plus protease and
phosphatase inhibitors) as previously described (Kulka et al.,
2003, 2009). Fractions were stored in aliquots at 70 1C. Protein
concentrations were determined using the BCA-200 Protein Assay
(Pierce) according to the manufacturer’s instructions.
Reverse transcription and quantitative PCR
Total cytoplasmic RNAs from infected or mock-infected cells
were subjected to DNase I digestion, phenol:chloroform:isoamyl
alcohol (Invitrogen) extraction and ethanol precipitation prior to
reverse transcription (1 mg RNA per reaction) with AMV reverse
transcriptase (RT) using the following primer sequences: HAV
sense: 50 CCGTTTGCCTAGGCTATAGGCTA 30; HAV anti-sense:
50 CAGCTCCATGC TAATCATGGAGT 30 to detect the presence of
viral negative strand RNA as previously described (Kulka et al.
2009). PCR primers were obtained from Loftstrand Labs, Ltd
(Gaithersburg, MD). Following reverse transcription, qPCR ampli-
ﬁcation was performed in the Applied Biosystems 7900 HT.
Brieﬂy, real-time PCR was performed using 96 well plates con-
taining sample cDNA (2.5 ml) in a 50 ml volume with TaqMan 2X
Universal PCR master mix (Applied Biosystems, manufactured by
Roche, Branchburg, NJ), and forward and reverse primers (0.4 mM)
and FAM-labeled probe (150 nM) were used as previously
described (Jothikumar et al., 2005). Primers and probe for q-PCR
were obtained from Integrated DNA Technologies, Coralville, IA.
All samples were tested in duplicate, with a sample containing no
template as negative control. The thermal cycler proﬁle was as
follows: 50 1C for 2 min, 95 1C for 10 min, then 95 1C for 15 s,
60 1C for 1 min for 40 cycles, followed by 1 h 20 min at room
temperature. PCR products were analyzed by agarose gel electro-
phoresis (Goswami et al., 2004).
PAGE and western blot analyses
Equal amounts of protein (RIPA) extracts were adjusted to
equivalent volumes in denaturing sample buffer containing
100 mM DTT, heated at 95–98 1C for 5–10 min and subjected to
SDS-PAGE [4–12% Bis-Tris gels using MOPS-SDS running buffer
(Invitrogen)] under reducing conditions, followed by semi-dry
electrophoretic transfer onto nitrocellulose membranes using a
three buffer transfer system based on manufacturer’s instructions
(Owl Separation Systems, Portsmouth, NH). Western blot analysis
S.Q. Wales et al. / Virology 430 (2012) 30–42 41was performed as previously described for antibodies to HAV VP1,
caspase-3, and actin (Kulka et al., 2003, 2009; Goswami et al.,
2004) and primary antibodies were diluted (anti-VP1 and anti-
actin at 1:2000; anti-caspase-3 at 1:1000) in TBS-T containing 5%
nonfat dry milk (NFDM) for overnight incubation at 4 1C. Second-
ary antibody-HRP conjugates were used at a 1:10,000 dilution in
TBS-T/5% NFDM for 1 h incubation at RT and subsequent detec-
tion by chemiluminescence was as previously described (Kulka
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